Weightwatchers International Inc.

WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: North America, United Kingdom, Continental Europe and Other. The North America segment consists of United States and Canada company-owned operations. The United Kingdom segment includes United Kingdom company-owned operations. The Continental Europe segment consists of Germany, Switzerland, France, Spain, Belgium, Netherlands, and Sweden company-owned operations. The others segment offers Australia, New Zealand company-owned operations, as well as revenues and costs from franchises in the United States. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Weight Watchers to Lead Clinical Weight Management with Strategic Acquisitions

Weight Watchers International is confident in its ability to return to a growth trajectory by providing science-based solutions for weight management. The company's strategic acquisitions, enhanced marketing approach, and product enhancements position it well for future success in the weight management industry.

Weight Watchers beats Q1 targets, eyes growth through digital

Weight Watchers International's Q1 2023 performance exceeded expectations with strong subscriber growth and revenue results.
The company's focus on digital expansion, data-informed culture, and strategic acquisitions positions it well for future growth.
Challenges include intensifying competition, sustaining growth amidst lower marketing spend, and successful integration of acquisitions.
Opportunities lie in enhancing member experience, expanding in the clinical space, and leveraging brand equity for efficient growth.

WeightWatchers reports subscriber growth despite revenue challenges and supply shortages

WeightWatchers International is navigating challenges in revenue due to clinical supply shortages but is focusing on core business growth and member engagement. The company's strategic focus on weight health leadership and synergies between its core and clinical businesses present opportunities for growth and innovation.

Weight Watchers reports strong Q3 performance, eyes growth opportunities

Weight Watchers International (WW) delivered a strong performance in Q3, with notable subscriber growth, revenue, and margin expansion. The company's strategic focus on innovation, partnerships, and cost efficiency underpins its resilience and market competitiveness.
While facing challenges such as supply constraints and uncertainties in future guidance, Weight Watchers remains committed to sustainable growth through subscriber-centric strategies and operational agility. Opportunities lie in expanding Clinical offerings, targeted programs, and industry engagement.
Overall, Weight Watchers' Q3 earnings call highlights its financial strength, strategic direction, and commitment to driving subscriber growth and engagement. The company's performance underscores its ability to adapt, innovate, and navigate challenges in the competitive landscape.

Weight Watchers focuses on health, sees growth in subscribers

Weight Watchers International Inc. is prioritizing growth in clinical subscribers and subscription revenue, focusing on enhancing digital products, and differentiating itself through science and brand equity. The company is confident in delivering year-over-year growth in various key metrics for 2024.

WeightWatchers International Inc. reports strong Q1 performance and strategic growth initiatives

WeightWatchers International Inc. delivered a strong performance in Q1 2024, showcasing growth in clinical business, record margins, and strategic initiatives to drive long-term growth. While facing challenges in marketing strategy shifts and restructuring costs, the company is well-positioned to capitalize on opportunities in subscriber ARPU stabilization, B2B partnerships, and product enhancements.

WeightWatchers anticipates growth amidst challenges, emphasizes cost-saving measures

WeightWatchers International faces short-term challenges but remains optimistic about its financial performance for the year. The company is implementing cost-saving measures, focusing on strategic growth initiatives, and emphasizing the importance of expanding access and care options.

WeightWatchers reports Q3 revenue decline but focuses on growth

WeightWatchers International is navigating challenges while leveraging strengths to drive growth and operational efficiency.
The company's focus on innovation, brand revitalization, and cost savings aligns with long-term growth objectives.
Despite market dynamics, WeightWatchers remains optimistic about future demand and committed to strategic initiatives for turnaround.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK, May 15, 2023 (GLOBE NEWSWIRE) -- WW International, Inc., (NASDAQ: WW) known as WeightWatchers , announced today that Tara Comonte, CEO of TMRW Life Sciences, Inc. (TMRW), has been appointed to the WeightWatchers Board of Directors, effective as of June 1, 2023.

Tara Comonte, CEO TMRW Life Sciences, to Join WW International, Inc. Board of Directors

WW International Inc.'s stock WW tumbled 13% premarket Thursday, after the company formerly called Weight Watchers said Artal Group S.A., a former controlling shareholder, has sold its remaining stake in the company.

WW International stock tumbles 13% after former controlling shareholder Artal sells its remaining stake

NEW YORK, May 10, 2023 (GLOBE NEWSWIRE) --  WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its former controlling shareholder Artal Group S.A. (“Artal”) has sold its remaining minority stake in the Company in a Rule 144 block trade. Artal purchased the Company in 1999 from Heinz and maintained a controlling interest from its initial public offering in 2001 through 2018.

WW International, Inc. Announces that Artal Group S.A. Has Sold Its Remaining Stake of WW Common Stock

The first quarter earnings report demonstrated signs of stabilization in the core business, indicating management's view on a return to growth in the 2nd half is achievable. While the focus remains on integrating the Sequence acquisition, we view this as complementary to improved core member acquisition.

WW International: Encouraging Signs, Remain Positive

WW International (WW), the weight-loss program operator, said it expects to end 2023 with total subscribers approaching 3.6 million, including 3.5 million WeightWatchers subscribers. CEO Sima Sistani told investors that increasing subscribers is a “notable achievement” as the last time the company ended a year with flat or higher subscribers year-over-year was in 2020.

WW International expects to end 2023 with 3.6M subscribers, beats 1Q estimates

WW International, Inc. (NASDAQ:WW ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Corey Kinger - Investor Relations Sima Sistani - Chief Executive Officer Heather Stark - Chief Financial Officer Conference Call Participants Jason English - Goldman Sachs Linda Bolton-Weiser - D.A. Davidson Henry Carr - UBS Nathan Feather - Morgan Stanley Alex Fuhrman - Craig-Hallum Operator Good day, and welcome to the WW International Incorporated First Quarter 2023 Earnings Conference Call.

WW International, Inc. (WW) Q1 2023 Earnings Call Transcript

WW International (WW) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.12 per share a year ago.

WW International (WW) Reports Q1 Loss, Tops Revenue Estimates

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its results for the first quarter of fiscal 2023.

WW International, Inc. Announces First Quarter 2023 Results

NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the first quarter 2023 after market close on Thursday, May 4, 2023.

WW International, Inc. Schedules First Quarter 2023 Earnings Conference Call

Shares of WeightWatchers' parent have been soaring after multiple analysts' upgrades. WW has acquired a telehealth company that focuses on chronic weight management.

Can WW International Stock Double? Goldman Sachs Thinks So

The decision to get into the obesity-medication business for drugs such as Ozempic makes sense as it tries to turn a declining business around.

WeightWatchers Gets a Makeover With Obesity-Drug Business

Cushman & Wakefield plc

JetBlue Airways

LendingClub

LG Display Co.

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

5 Recognizable ‘Strong Buy' Stocks Trading Under $10 With Huge Upside Potential

WW International Inc. ( WW , Financial), formerly known as Weight Watchers, announced last month its plans to acquire Sequence, a telehealth platform with a focus on weight loss drugs.

WW International: Approach With Caution

WW International's newly acquired telehealth unit—which specializes in helping patients get prescription weight management drugs like Ozempic—could serve as an "on-ramp" to the company's traditional weight loss programs, Goldman Sachs says.

Shares Of Weight Watchers Parent Surge 60% After Pivot To Ozempic

Weight management food and services provider WW International Inc. (NYSE: WW) stock took a 25% spike as it closed its acquisition of telehealth weight loss platform provider Sequence Inc. WW, formerly known as Weight Watchers, has been on a downward trajectory during its restructuring with mounting (paper) losses. Its membership ended in 2022 at 3.5 million.

Weight Watchers Reshapes Itself with a Game-Changer Acquisition

One of the season's biggest market winners just got more good news. WW International (NASDAQ: WW ), known previously as Weight Watchers, has announced the closing of its acquisition of telehealth firm Sequence.

WW Stock Price Prediction: Why This Analyst Says WW International Could Soar 216%

Weight Watchers International (NASDAQ:WW) told investors it has completed its acquisition of Weekend Health, doing business as Sequence, a subscription telehealth platform offering access to doctors who can prescribe weight-loss drugs such as Ozempic and Wegovy. Its shares surged more than 40% in early trade.

Weight Watchers International soars as it confirms expansion into fat-loss injection market

WW International Inc (NASDAQ:WW) stock is soaring today, after Goldman Sachs upgraded the WeightWatchers parent to "buy" from "neutral," with a price-target hike to $13 from $3.80.

WeightWatchers Stock Skyrockets on Upgrade

Shares of WW International Inc. WW, -1.20% , which was formerly known as Weight Watchers, soared 25.2% toward a five-week high in premarket trading Tuesday, after the weight management and wellness company said it completed its acquisition of Weekend Health Inc., the telehealth company doing business as Sequence. The stock had rocketed 79.1% to a seven-month high of $6.93 on March 7 after the $132 million deal was announced, as the acquisition would provide WW a telehealth provider that prescribes weight-management and diabetes drugs.

Weight Watchers parent's stock soars after deal to buy weight-management drugs prescriber Sequence closes

NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced it has completed its acquisition of Weekend Health, Inc., d/b/a Sequence, a subscription telehealth platform offering access to healthcare providers specializing in chronic weight management. Sequence seamlessly integrates the patient and clinician experience for medication management and related clinical care while providing high-touch support in navigating the insurance approval process.

WW International, Inc. Completes Acquisition of Sequence

Agora

VirnetX

The stock market is down today because recession fears are returning to

3 Hot Penny Stocks To Watch With The Stock Market Down Today

Eli Lilly

Novo Nordisk

Novo Nordisk's business has been red-hot, thanks to soaring obesity-related revenue. Eli Lilly has its own promising weight-loss treatment which could be a game changer.

3 Stocks That Could Benefit From the Ozempic Craze

CVS Health

Teladoc

Healthcare tends to be a great place to hide during periods of uncertainty, and considering the best telehealth stocks to buy is one way to do more than just hide. There are several big trends emerging in healthcare right now, and most point to growth in online, at-home medical attention.

3 Top Stock Picks to Profit From the Telehealth Boom

WW International Inc. WW, +0.71% , the parent company of Weight Watchers, said late Thursday its chairman would not stand for re-election, and is stepping down. Raymond Debbane, the current chair, will step down the day before the company's May 9 annual meeting, WW said, with the board appointing Thilo Semmelbauer as chairman-elect.

Weight Watchers chairman to step down in May

NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced several upcoming changes to its Board of Directors (the “Board”) in connection with the Company's annual meeting of shareholders to be held on May 9, 2023 (the “2023 Annual Meeting”).

News for Weightwatchers International Inc. Stock (WW)